India to run vaccine trial in Bangladesh

Our Correspondent

30 October, 2020 12:00 AM printer

New Delhi: The clinical trial of an experimental Indian Covid-19 vaccine will take place in Bangladesh, Spokesperson of External Affairs Ministry Anurag Sribastav said in New Delhi on Thursday.

He further said Indian Health Ministry and the authority concerned had a discussion with the counterpart of Bangladesh on October 17-19 and it was decided that Indian vaccine will be put under clinical trial in Bangladesh.

The detail of the scheme is being worked out. An Indian delegation came to Dhaka to discuss in details.

Indian vaccine company Serum Institute, the largest producer of all kinds of vaccines in the world had made an arrangement with Bangladesh leading pharmaceutical company Bexmico for joint production of the Covid-19 vaccine.  In the agreement, it was mentioned that once the vaccine is available in the market, Bangladesh will get it first. In the last Joint Consultative Commission by the Foreign Minister of the two countries, it was decided both the countries will cooperate on the vaccine.

The spokesperson also said Prime Minister Narendra Modi has also assured that once the Indian vaccine is ready, neighbouring countries will get priority access to it.

Other than Bangladesh, India had also discussed with Myanmar as they were interested in the same exercise.

On Air Bubble, the spokesperson said India and Bangladesh have agreed for this special commercial flight to carry passengers of both countries only. Major airlines will soon start flying to India and Bangladesh. This has been done mainly to facilitate the journey of those who need medical treatment in India urgently.